We closely monitor every aspect of your treatment, ensuring safety and efficacy
Yes, glutathione protects the eyes from oxidative damage and age-related eye diseases such as cataracts and AMD
The 2026 Part D out-of-pocket cap is $2,100
Glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as effective therapies for multiple metabolic disorders, demonstrating significant benefits in weight management and cardiovascular risk reduction in individuals with obesity or type 2 diabetes (T2D) 6,7,8 .The 2025 American Diabetes Association (ADA) Standards of Care have broadened the use of GLP-1R agonists beyond glycemic control, recommending them for patients with T2D and chronic kidney disease, as well as those with T2D, obesity, or prediabetic individuals with nonalcoholic fatty liver disease and heart failure with preserved ejection fraction 9
It does not interfere with routine laboratory assays
While GHK-Cu demonstrates excellent safety, confirming normal values periodically represents prudent practice for any extended intervention
